Back to Journals » Core Evidence » Volume 4 » default

Core Evidence


Archive: Volume 4, 2009

Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation

Peter Deibert, Carola Xander, Hubert E Blum, et al

Core Evidence 2009, 4:247-258

Published Date: 11 December 2009

Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy

Paul Richardson, Constantine Mitsiades, Jacob Laubach, et al

Core Evidence 2009, 4:215-245

Published Date: 17 November 2009

Nilotinib for the treatment of chronic myeloid leukemia: An evidence-based review

Elias Jabbour, Jorge Cortes, Hagop Kantarjian

Core Evidence 2009, 4:207-213

Published Date: 5 October 2009

Trabectedin: the evidence for its place in therapy in the treatment of soft tissue sarcoma

Katherine A Thornton

Core Evidence 2009, 4:191-198

Published Date: 21 August 2009

Agomelatine: The evidence for its place in the treatment of depression

Daniela Eser, Thomas C Baghai, Hans-Jürgen Möller

Core Evidence 2009, 4:171-179

Published Date: 5 August 2009

Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection

Hans-Jürgen Stellbrink

Core Evidence 2009, 4:149-158

Published Date: 22 July 2009

Raltegravir: The evidence of its therapeutic value in HIV-1 infection

Kavya Ramkumar, Nouri Neamati

Core Evidence 2009, 4:131-147

Published Date: 2 July 2009

Lasofoxifene: Evidence of its therapeutic value in osteoporosis

Luigi Gennari, Daniela Merlotti, Vincenzo De Paola, Ranuccio Nuti

Core Evidence 2009, 4:113-129

Published Date: 1 July 2009

Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas

Ayman I Omar, Warren P Mason

Core Evidence 2009, 4:93-111

Published Date: 26 June 2009

Conivaptan: Evidence supporting its therapeutic use in hyponatremia

Melissa Li-Ng, Joseph G Verbalis

Core Evidence 2009, 4:83-92

Published Date: 25 June 2009

Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy

Daniel Z Lieberman, Suena H Massey

Core Evidence 2009, 4:67-82

Published Date: 25 June 2009

Eptifibatide: The evidence for its role in the management of acute coronary syndromes

Ibrahim Shah, Shakeel O Khan, Surender Malhotra, Tim Fischell

Core Evidence 2009, 4:49-65

Published Date: 18 June 2009

Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer

Hari A Deshpande, Scott Gettinger, Julie Ann Sosa

Core Evidence 2009, 4:43-48

Published Date: 10 June 2009

Indacaterol: a new once daily long-acting beta2 adrenoceptor agonist

Kai M Beeh, Jutta Beier

Core Evidence 2009, 4:37-41

Published Date: 18 June 2009

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout

Angelo L Gaffo, Kenneth G Saag

Core Evidence 2009, 4:25-36

Published Date: 23 June 2009

Exforge® (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact

Jean-Marie Krzesinski, Eric P Cohen

Core Evidence 2009, 4:1-11

Published Date: 17 June 2009